Crossmark

Early relapse of atypical hemolytic uremic syndrome following ABO-incompatible living–related pediatric kidney re-transplant successfully treated with eculizumab

Crossref DOI link: https://doi.org/10.1007/s00467-021-05193-7

Published Online: 2021-07-17

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stojanovic, Jelena https://orcid.org/0000-0001-9887-9081
Adamusiak, Anna

Waters, Aoife

Sebire, Neil J.

Kessaris, Nicos

Mamode, Nizam

Marks, Stephen D.
License Information

Text and Data Mining valid from 2021-07-17

Version of Record valid from 2021-07-17
More Information

Article History

Received: 5 April 2021

Revised: 8 June 2021

Accepted: 8 June 2021

First Online: 17 July 2021

Declarations

:

: The authors declare no competing interests.

: The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.

Document is current

Any future updates will be listed below